Peer-influenced content. Sources you trust. No registration required. This is HCN.

The New England Journal of MedicineInterrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer

Temporary suspension of endocrine medication to seek pregnancy did not give a higher short-term risk of breast cancer events, including distant recurrence, than the external control cohort among select women with previous hormone receptor-positive (HR+) early breast cancer. Further investigation is required to ensure long-term safety.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form